# Pharmaceutical Treatments for Typical CKD Comorbidities

**Authors:** Manuela Di Lauro, Annalisa Noce

PMC · DOI: 10.3390/biomedicines14020401 · Biomedicines · 2026-02-10

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** metabolic disturbances (MESH:D024821), platelet aggregation (MESH:D001791), uremic sarcopenia (MESH:D055948), chronic inflammation (MESH:D007249), Uremia (MESH:D014511), injury to (MESH:D014947), impaired physical performance (MESH:D059445), malignancy (MESH:D009369), Diabetes mellitus (MESH:D003920), Counteract Endothelial Dysfunction (MESH:D014652), HD (MESH:D006816), CKD (MESH:D051436), falls (MESH:C537863), Disorders of mineral and bone metabolism (MESH:D001851), bone demineralization (MESH:D018488), bone fragility (MESH:C536063), frailty (MESH:D000073496), loss of muscle mass (MESH:C536030), albuminuria (MESH:D000419), thrombosis (MESH:D013927), vascular calcification (MESH:D061205), atherosclerosis (MESH:D050197), hypertension (MESH:D006973), ESRD (MESH:D007676), immune dysfunction (MESH:D007154), infections (MESH:D007239), CV and (MESH:D002318), CKD-MBD (MESH:D012080), Metabolic acidosis (MESH:D000138), nephropathy (MESH:D007674), immune dysregulation (OMIM:614878), chronic (MESH:D002908)
- **Chemicals:** vitamin D (MESH:D014807), phosphate (MESH:D010710), olive oil (MESH:D000069463), ketoanalogue (-), calcium (MESH:D002118), finerenone (MESH:C576501)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938269/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938269/full.md

---
Source: https://tomesphere.com/paper/PMC12938269